Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Koushik Kondapi"'
Publikováno v:
American Journal of Clinical Dermatology. 23:755-773
Autor:
Mukesh K. Nyati, Theodore S. Lawrence, William B. Pratt, Yoichi Osawa, Yoshihiro Morishima, Manjunath P. Pai, Venkatesha Basrur, Dafydd G. Thomas, Matthew J. Schipper, Theresa Devasia, Cuyler Dewar, Merna Sitto, Koushik Kondapi, Sanjima Pal, Ranjit K. Mehta
Supplementary Table III: Pharmacokinetics Data of AT13387
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92878cbd093c14cd543af1c9be90b280
https://doi.org/10.1158/1078-0432.22476600.v1
https://doi.org/10.1158/1078-0432.22476600.v1
Autor:
Mukesh K. Nyati, Theodore S. Lawrence, William B. Pratt, Yoichi Osawa, Yoshihiro Morishima, Manjunath P. Pai, Venkatesha Basrur, Dafydd G. Thomas, Matthew J. Schipper, Theresa Devasia, Cuyler Dewar, Merna Sitto, Koushik Kondapi, Sanjima Pal, Ranjit K. Mehta
Supplementary figure 1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf6d21d6fc665f9612d669728369171
https://doi.org/10.1158/1078-0432.22476612
https://doi.org/10.1158/1078-0432.22476612
Autor:
Mukesh K. Nyati, Theodore S. Lawrence, William B. Pratt, Yoichi Osawa, Yoshihiro Morishima, Manjunath P. Pai, Venkatesha Basrur, Dafydd G. Thomas, Matthew J. Schipper, Theresa Devasia, Cuyler Dewar, Merna Sitto, Koushik Kondapi, Sanjima Pal, Ranjit K. Mehta
Purpose:Treatment approaches using Hsp90 inhibitors at their maximum tolerated doses (MTDs) have not produced selective tumor toxicity. Inhibition of Hsp90 activity causes degradation of client proteins including those involved in recognizing and rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55b719b21d1e3a88e3d54d738a2098f3
https://doi.org/10.1158/1078-0432.c.6529434
https://doi.org/10.1158/1078-0432.c.6529434
Autor:
Mukesh K. Nyati, Theodore S. Lawrence, William B. Pratt, Yoichi Osawa, Yoshihiro Morishima, Manjunath P. Pai, Venkatesha Basrur, Dafydd G. Thomas, Matthew J. Schipper, Theresa Devasia, Cuyler Dewar, Merna Sitto, Koushik Kondapi, Sanjima Pal, Ranjit K. Mehta
Supplementary Table I: list of clinical studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dfb83a46ecab9de0306d4f08e40dc8e
https://doi.org/10.1158/1078-0432.22476606.v1
https://doi.org/10.1158/1078-0432.22476606.v1
Autor:
Mukesh K. Nyati, Theodore S. Lawrence, William B. Pratt, Yoichi Osawa, Yoshihiro Morishima, Manjunath P. Pai, Venkatesha Basrur, Dafydd G. Thomas, Matthew J. Schipper, Theresa Devasia, Cuyler Dewar, Merna Sitto, Koushik Kondapi, Sanjima Pal, Ranjit K. Mehta
Functional Annotation Chart for significantly down regulated proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42b2bdc96155e0a780a1099932e0886f
https://doi.org/10.1158/1078-0432.22476597
https://doi.org/10.1158/1078-0432.22476597
Autor:
Mukesh K. Nyati, Theodore S. Lawrence, William B. Pratt, Yoichi Osawa, Yoshihiro Morishima, Manjunath P. Pai, Venkatesha Basrur, Dafydd G. Thomas, Matthew J. Schipper, Theresa Devasia, Cuyler Dewar, Merna Sitto, Koushik Kondapi, Sanjima Pal, Ranjit K. Mehta
Supplementary Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5a046e7cf464dd9c4f016dacd72a6c7
https://doi.org/10.1158/1078-0432.22476609.v1
https://doi.org/10.1158/1078-0432.22476609.v1
Autor:
Mukesh K. Nyati, Theodore S. Lawrence, William B. Pratt, Yoichi Osawa, Yoshihiro Morishima, Manjunath P. Pai, Venkatesha Basrur, Dafydd G. Thomas, Matthew J. Schipper, Theresa Devasia, Cuyler Dewar, Merna Sitto, Koushik Kondapi, Sanjima Pal, Ranjit K. Mehta
List of proteins identified in TMT-LC/MS assay and list of enriched pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::066828917d4ab77131f2653ea75d7bb2
https://doi.org/10.1158/1078-0432.22476603
https://doi.org/10.1158/1078-0432.22476603
Publikováno v:
Radiol Cardiothorac Imaging
Autor:
Theodore S. Lawrence, William B. Pratt, Cuyler Dewar, Yoshihiro Morishima, Venkatesha Basrur, Manjunath P. Pai, Koushik Kondapi, Merna Sitto, Mukesh K. Nyati, Sanjima Pal, Dafydd G. Thomas, Theresa Devasia, Ranjit K. Mehta, Matthew J. Schipper, Yoichi Osawa
Publikováno v:
Clin Cancer Res
Purpose:Treatment approaches using Hsp90 inhibitors at their maximum tolerated doses (MTDs) have not produced selective tumor toxicity. Inhibition of Hsp90 activity causes degradation of client proteins including those involved in recognizing and rep